Lukang Pharmaceutical

Striving to develop for 50 years
Caring for human health
News Center
Date: 2021.05.21
Lukang Pharma shortlisted in China's top 100 drug R&D companies

In February 2021, at the Fifth China Pharma R&D and Innovation Summit, the series of "2020 China Drug R&D Strength Rankings" was released. Lukang Pharma ranked 99th and 82nd in comprehensive and chemical drug R&D strength, it was the first time to be shortlisted in the China's top 100 drug R&D companies. In 2015, Lukang Pharma put forward product structure transformation and emphasized R&D. Five years later, the company's R&D level and comprehensive strength have been significantly improved, and it has emerged in the R&D ranking of large-scale enterprises.